Nordic NECT - Trials

Navigation

	Trials
Open for inclusion Inclusion completed	Phase I/II study of lenalidomide and gemcitabine as first-line treatment in patients with locally advanced or metastatic pancreatic cancer Cancer type: Pancreatic cancer Phase: I/II Principal Investigator: Liljefors Maria Country: SE Keywords: Sweden, lenalidomide, first line, advanced or metastatic pancreatic cancer Status: Inclusion completed